Document Detail

Graphic reanalysis of the two NINDS-tPA trials confirms substantial treatment benefit.
MedLine Citation:
PMID:  20829518     Owner:  NLM     Status:  MEDLINE    
BACKGROUND AND PURPOSE: Multiple statistical analyses of the 2 NINDS-tPA trials have confirmed study findings of benefit of fibrinolytic therapy. A recent graphic analysis departed from best practices in the visual display of quantitative information by failing to take into account the skewed functional importance of NIH Stroke Scale raw scores and by scaling change axes at up to 20 times the range achievable by individual patients.
METHODS: Using the publicly available datasets of the 2 NINDS-tPA trials, we generated a variety of figures appropriate to the characteristics of acute stroke trial data.
RESULTS: A diverse array of figures all visually delineated substantial benefits of fibrinolytic therapy, including: bar charts of normalized gain and loss; stacked bar, bar, and matrix plots of clinically relevant ordinal ranks; a time series stacked line plot of continuous scale disability weights; and line plot, bubble chart, and person icon array graphs of joint outcome table analysis. The achievable change figure showed substantially greater improvement among tPA than placebo patients, median 66.7% (interquartile range, 0 to 92.0) versus 50.0% (interquartile range, -7.1 to 80.0), P=0.003.
CONCLUSIONS: On average, under 3 hour patients treated with tPA recovered two-thirds while placebo patients improved only half of the way toward fully normal. Graphical analyses of the 2 NINDS-tPA trials, when performed according to best practices, is a useful means of conveying details about patient response to therapy not fully delineated by summary statistics, and confirms a valuable treatment benefit of under 3 hour fibrinolytic therapy in acute stroke.
Jeffrey L Saver; Jeffrey Gornbein; Sidney Starkman
Related Documents :
19164398 - Clinical evaluation of a non-immersive virtual environment in stroke rehabilitation.
14677218 - Treatment interventions for the paretic upper limb of stroke survivors: a critical review.
20562468 - White matter hyperintensities in post-stroke depression: a case control study.
19091088 - Impact of early applied upper limb stimulation: the explicit-stroke programme design.
25281508 - Differentiating maternal fatigue and depressive symptoms at six months and four years p...
9375888 - Preliminary core sets for endpoints in ankylosing spondylitis. assessments in ankylosin...
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't     Date:  2010-09-09
Journal Detail:
Title:  Stroke; a journal of cerebral circulation     Volume:  41     ISSN:  1524-4628     ISO Abbreviation:  Stroke     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-09-29     Completed Date:  2010-10-19     Revised Date:  2014-06-20    
Medline Journal Info:
Nlm Unique ID:  0235266     Medline TA:  Stroke     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2381-90     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Brain Ischemia / drug therapy*
Clinical Trials as Topic
Fibrinolytic Agents / therapeutic use
National Institute of Neurological Disorders and Stroke
Stroke / drug therapy*
Tissue Plasminogen Activator / therapeutic use*
Treatment Outcome
United States
Grant Support
Reg. No./Substance:
0/Fibrinolytic Agents; EC Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Childhood Posterior Circulation Arterial Ischemic Stroke.
Next Document:  Comparison of outcomes on continuous ambulatory peritoneal dialysis versus automated peritoneal dial...